Sphingolipids and neuronal degeneration in lysosomal storage disorders

J Neurochem. 2019 Mar;148(5):600-611. doi: 10.1111/jnc.14540. Epub 2018 Aug 16.

Abstract

Ceramide, sphingomyelin, and glycosphingolipids (both neutral and acidic) are characterized by the presence in the lipid moiety of an aliphatic base known as sphingosine. Altogether, they are called sphingolipids and are particularly abundant in neuronal plasma membranes, where, via interactions with the other membrane lipids and membrane proteins, they play a specific role in modulating the cell signaling processes. The metabolic pathways determining the plasma membrane sphingolipid composition are thus the key point for functional changes of the cell properties. Unnatural changes of the neuronal properties are observed in sphingolipidoses, lysosomal storage diseases occurring when a lysosomal sphingolipid hydrolase is not working, leading to the accumulation of the substrate and to its distribution to all the cell membranes interacting with lysosomes. Moreover, secondary accumulation of sphingolipids is a common trait of other lysosomal storage diseases. This article is part of the Special Issue "Lysosomal Storage Disorders".

Keywords: gangliosides; lysosome; membrane fusion; sphingolipidoses; sphingolipids; sphingomyelin.

Publication types

  • Review

MeSH terms

  • Animals
  • Humans
  • Lysosomal Storage Diseases / metabolism*
  • Lysosomal Storage Diseases / pathology
  • Lysosomes / metabolism
  • Lysosomes / pathology
  • Nerve Degeneration / metabolism*
  • Nerve Degeneration / pathology
  • Sphingolipidoses / metabolism*
  • Sphingolipidoses / pathology
  • Sphingolipids / metabolism*

Substances

  • Sphingolipids